US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 87.250
  • -1.590-1.79%
Close Nov 4 16:00 ET
  • 87.500
  • +0.250+0.29%
Post 17:26 ET
4.19BMarket Cap-13259P/E (TTM)

Axsome Therapeutics Key Stats

Axsome Therapeutics Q3 2024 Estimates Date

Currency:USDNov 12, 2024

Estimate YoY
Revenue
98.07M
+69.69%
EPS
-1.41
-6.86%
Strong Buy

Nov 4, 2024

Axsome Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 112.899M--
Nov 12, 20242024/Q3-- / 98.072M--
Aug 5, 20242024/Q287.166M / 86.933M--
May 6, 20242024/Q174.999M / 72.852M--
Feb 20, 20242023/Q471.531M / 69.036M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 112.899M--
Nov 12, 20242024/Q3-- / 98.072M--
Aug 5, 20242024/Q287.166M / 86.933M--
May 6, 20242024/Q174.999M / 72.852M--
Feb 20, 20242023/Q471.531M / 69.036M--

Unlock Free Earnings Estimates

Axsome Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 4, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data